HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.

Abstract
In a double-blind, randomised group comparative study the efficacy of daily oral administration of 100 mg and 200 mg torasemide (1-isopropyl-3-([4-(3-methyl-phenylamino)pyridine]-3-sulfonyl)urea) were compared with that of 250 mg furosemide over 2 weeks in patients with advanced chronic renal failure, who had been pretreated with a maintenance therapy of 500 mg furosemide per day. Of the 19 patients 7 had been allocated strictly at random to 100 mg torasemide, 6 to 200 mg torasemide and 6 patients to 250 mg furosemide. The volume excretion after administration of 200 mg torasemide was significantly higher than after administration of 250 mg furosemide and non-significantly higher than after 100 mg torasemide. In comparison with baseline values under pretreatment with 500 mg furosemide there was a slight reduction of fluid and sodium excretion in the 100 mg torasemide group and a clear reduction in the 250 mg furosemide group. In contrast, in the 200 mg torasemide group excretion of fluid and sodium increased. The tolerance was good in all 3 groups.
AuthorsJ Kult, W Häcker, M Glocke
JournalArzneimittel-Forschung (Arzneimittelforschung) Vol. 38 Issue 1A Pg. 212-4 (Jan 1988) ISSN: 0004-4172 [Print] Germany
PMID3285837 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Diuretics
  • Electrolytes
  • Sulfonamides
  • Uric Acid
  • Furosemide
  • Sodium
  • Creatinine
  • Torsemide
Topics
  • Adult
  • Aged
  • Blood Pressure (drug effects)
  • Body Weight (drug effects)
  • Clinical Trials as Topic
  • Creatinine (urine)
  • Diuretics (administration & dosage, adverse effects, therapeutic use)
  • Double-Blind Method
  • Electrolytes (urine)
  • Female
  • Furosemide (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Kidney Failure, Chronic (drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Random Allocation
  • Sodium (urine)
  • Sulfonamides (administration & dosage, adverse effects, therapeutic use)
  • Torsemide
  • Uric Acid (urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: